Functions of the N-Terminal Domain of Secretory Leukoprotease Inhibitor
- 1 May 1994
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 33 (18), 5445-5450
- https://doi.org/10.1021/bi00184a013
Abstract
Secretory leukoprotease inhibitor (SLPI) comprises two homologous domains: the C-terminal domain contains the reactive site, while the function of the N-terminal domain remains unknown. In order to elucidate the function of the N-terminal domain, we studied the kinetics of reactions of human leukocyte elastase with two recombinant forms of SLPI: the full-length inhibitor and the C-terminal domain alone. The reactions of elastase with the full-length inhibitor and the C-terminal domain share the same association rate constant, 2 x 10(6) M-1 s-1, but the complex formed with the C-terminal domain is less stable, with a dissociation rate constant of 8 x 10(-4) s-1, 5 times higher than that of the complex with the full-length inhibitor. The binding of the full-length inhibitor to elastase is greatly accelerated by polyanions. In the presence of submicromolar concentrations (1 microgram/mL) of heparin, the association rate constant is increased by more than 1 order of magnitude. The binding of the C-terminal domain alone to elastase shows much lower sensitivity to heparin; in the presence of 5 microM (25 micrograms/mL) heparin, association of the C-terminal domain with elastase reaches a maximum rate of 7 x 10(6) M-1 s-1, about 3 times higher than the rate in the absence of heparin. Similar differential effects of heparin have been observed on the reactions of alpha-chymotrypsin with the two recombinant forms of SLPI.2=This publication has 34 references indexed in Scilit:
- Kinetics of substrate reaction during irreversible modification of enzyme activity where the modifier is not in great excess of the enzymeJournal of Theoretical Biology, 1992
- Synthesis and structure-activity relationships of elafin, an elastase-specific inhibitorBiochemical and Biophysical Research Communications, 1992
- Separation of the two domains of human mucus proteinase inhibitor: Inhibitory activity is only located in the car☐y-terminal domainBiochemical and Biophysical Research Communications, 1991
- Proteinase inhibitory activities of antileukoprotease are represented by its second COOH-terminal domainBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1990
- Tissue distribution of antileukoprotease and lysozyme in humans.Journal of Histochemistry & Cytochemistry, 1989
- Mucus proteinase inhibitor: a fast-acting inhibitor of leucocyte elastaseBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1989
- The acid‐stable proteinase inhibitor of human mucous secretions (HUSI‐I, antileukoprotease)FEBS Letters, 1986
- In vivo significance of kinetic constants of protein proteinase inhibitorsBiochemical Medicine, 1984
- Interaction between human leukocyte elastase and chondroitin sulfateChemico-Biological Interactions, 1984
- Kinetics of the inhibition of leukocyte elastase by the bronchial inhibitorBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1982